Inventor · disambiguated record
Antoni Ribas
Also filed as: RIBAS ANTONI
14 granted patents·10 pending applications·246 citations·filing 2007–2025
91Inventor score
Top patents by PatentIndex Score
24 records- 0196US8119772B2MART-1 T cell receptorsYANG LILI·Filed 2007·Granted Feb 21, 2012·136 cites·14 claims
- 0295US11590171B2Targeted replacement of endogenous T cell receptorsUNIV CALIFORNIA·Filed 2022·Granted Feb 28, 2023·2 cites·16 claims
- 0395US11331346B2Targeted replacement of endogenous T cell receptorsUNIV CALIFORNIA·Filed 2021·Granted May 17, 2022·5 cites·18 claims
- 0495US11033584B2Targeted replacement of endogenous T cell receptorsUNIV CALIFORNIA·Filed 2019·Granted Jun 15, 2021·12 cites·31 claims
- 0595US8394590B2Capture agents and related methods and systems for detecting and/or sorting targetsKWONG GABRIEL A·Filed 2010·Granted Mar 12, 2013·78 cites·14 claims
- 0692US11083753B1Targeted replacement of endogenous T cell receptorsROTH THEODORE LEE·Filed 2021·Granted Aug 10, 2021·8 cites·18 claims
- 0786US2025361287A1Targeted replacement of endogenous t cell receptorsUNIV CALIFORNIA·Filed 2025·Application pending·0 cites
- 0883US12398193B2Targeted replacement of endogenous T cell receptorsUNIV CALIFORNIA·Filed 2023·Granted Aug 26, 2025·0 cites·22 claims
- 0981US8552150B2MART-1 T cell receptorsYANG LILI·Filed 2012·Granted Oct 8, 2013·5 cites·20 claims
- 1055US2024299541A1Selective stimulation of t cells in solid tumors using oncolytic viral delivery of orthogonal il-2UNIV PENNSYLVANIA·Filed 2022·Application pending·0 cites
- 1153US2021386780A1Methods for treating cancer with double stranded rna sensor activators and adoptive cell therapyUNIV CALIFORNIA·Filed 2019·Application pending·0 cites
- 1252US2023049954A1Chimeric antigen receptors and related methods and compositions for the treatment of cancerUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 1349US12213977B2Methods and compositions for treating melanomaUNIV CALIFORNIA·Filed 2018·Granted Feb 4, 2025·0 cites·12 claims
- 1449US2021324035A1Composition of ny-eso-1-specific t cell receptors restricted on multiple major histocompatibility complex moleculesUNIV CALIFORNIA·Filed 2019·Application pending·0 cites
- 1549US2021161943A1Pak4 inhibitors and methods of useUNIV CALIFORNIA·Filed 2019·Application pending·0 cites
- 1647US11318164B2Immunotherapeutic treatment method using an interleukin-2 receptor beta-selective agonist in combination with adoptive cell transfer therapyNEKTAR THERAPEUTICS·Filed 2018·Granted May 3, 2022·0 cites·25 claims
- 1745US2019262343A1Wound healing using braf inhibitorsUNIV CALIFORNIA·Filed 2017·Application pending·0 cites
- 1840US10711312B2Methods for immunotherapy-based treatment and assessment of cancerUNIV CALIFORNIA·Filed 2017·Granted Jul 14, 2020·0 cites·17 claims
- 1940US2017100345A1Wound healing using braf inhibitorsUNIV CALIFORNIA·Filed 2015·Application pending·0 cites
- 2039US11275080B2Methods for stratifying non-responders to therapies that block PD1/PDL1 axisUNIV CALIFORNIA·Filed 2015·Granted Mar 15, 2022·0 cites·17 claims
- 2139US10201597B2Codon-optimized lentiviral vector for stem cell reprogrammingUNIV CALIFORNIA·Filed 2015·Granted Feb 12, 2019·0 cites·21 claims
- 2239US2022138939A1Systems and Methods for Digital PathologyUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 2329US10744116B2Detection and treatment of anti-PD-1 therapy resistant metastatic melanomasUNIV CALIFORNIA·Filed 2017·Granted Aug 18, 2020·0 cites·20 claims
- 2428US2013217721A1Compositions and methods for detection and treatment of b-raf inhibitor-resistant melanomasLO ROGER S·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Antoni Ribas files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →